Angioneurotic oedema with tadalafil: A rare case report
- PMID: 20703350
- PMCID: PMC2915601
- DOI: 10.4103/0019-5545.31562
Angioneurotic oedema with tadalafil: A rare case report
Abstract
A case is reported where the patient developed angioneurotic oedema of the lip after the use of tadalafil.1 On withdrawal of tadalafil, complete remission was obtained through required symptomatic treatment. Clinicians should be aware of the possibility of development of angioneurotic oedema in patients undergoing treatment with tadalafil.
Keywords: BSFI (Brief Sexual Function Inventory) scale; ED (erectile dysfunction); GAF (Global Assessment of Functioning) scale; Tadalafil.
References
-
- Doggrell SA. Comparison of clinical trials with sildenafil, vardenafil and tadalafil in erectile dysfunction. Expert Opin Pharmacother. 2005;6:75–84. - PubMed
-
- Matthew AF, Sajatovic M. Tadalafil, editors. Psychotrophic drug information handbook. New York: Lexi Comp. Inc; 2006. pp. 488–91.
-
- Greaves MW, Lawlor F. Angio-oedema: Manifestations and management. J Am Acad Dermatol. 1991;25:155–61. - PubMed
-
- Champion RH, Roberts SOB, Carpenter RG, et al. Urticaria and angio-oedema: A review of 554 cases. Br J Dermatol. 1969;81:588–97. - PubMed
-
- Shipley D, Ormerod AD. Drug-induced urticaria. Recognition and treatment. Am J Clin Dermatol. 2001;2:151–8. - PubMed
